American pharma company Johnson & Johnson has decided not to conduct local testing of a single shot of COVID-19 vaccine in the country. Also, the company is planning to expand the vaccine.
johnson and johnson’s corona vaccine
American pharmaceutical company Johnson & Johnson will no longer conduct local trials for its single-shot COVID-19 vaccine in India. The company says that earlier it had sought approval for testing here, but now it will not have to do so because India has abolished that requirement. Now they are planning how to increase the availability of the vaccine in India. This was said by the spokesperson of the company in an interview given to the Economic Times.
The Drug Controller General of India recently announced that COVID-19 vaccines that were permitted for restricted use by regulators in the US, UK, Europe and Japan or that were on the World Health Organisation’s emergency use list are now available in India. I will not have to go through the process of testing. “There is no longer a need for Johnson & Johnson to conduct clinical studies of a single-dose Jensen COVID-19 vaccine for clinical trials,” the spokesperson said in the interview. After India relaxed regulatory requirements for imported vaccines, J&J approached India’s drug regulator to conduct a bridging trial.
A government official said, “The company was seeking approval to conduct the bridging trial and did not seek exemption. Despite this, the company is entitled under the regulatory regime, which was implemented in April.”
The company has postponed plans to bring its vaccine to Europe after Johnson & Johnson complained of blood clots from the Corona vaccine. Earlier, the US has recommended a temporary ban on the Johnson & Johnson vaccine. At the same time, Australia has refused to buy this vaccine. Johnson & Johnson has said that it is making some delay in bringing its anti-coronavirus vaccine to Europe.
There was a complaint of blood clotting
Some rare cases of blood clots were reported in America from Johnson & Johnson’s corona vaccine. Which is being investigated. The US regulator said it was recommending a suspension of the company’s vaccine as it investigates reports of dangerous blood clots. In this regard, the company said that it is reviewing these cases in collaboration with European health authorities. Due to which the process of bringing the vaccine to Europe was postponed.
Also read: After Mukesh Ambani, Gautam Adani also got a setback, 3 out of 6 companies suffered huge losses
Facebook made a record, for the first time the market cap crossed $ 1 trillion, know the reason for the rise in the stock
.
